Do you need an en bloc capsulectomy?
It is the most argued-about decision in explant surgery, and the answer the community gives is not the answer the surgical consensus gives. Both are worth understanding before you walk into a consultation.
The short answer
For most people having implants removed because of systemic symptoms, en bloc is not required. Current surgical consensus reserves it for suspected or confirmed implant-associated cancer, and supports total capsulectomy — complete removal of the capsule, though not necessarily in one intact piece — for breast implant illness. En bloc involves a wider dissection and carries additional risk.
What the consensus actually says
The 2024 Breast Surgery Collaborative Community consensus statement, endorsed by the American Society of Plastic Surgeons, The Aesthetic Society and ISAPS, states that the only indication for en bloc capsulectomy is established or suspected breast implant-associated cancer following appropriate workup.
En bloc requires a more extensive dissection than total capsulectomy, with a higher reported risk of complications including haematoma and pneumothorax, and can remove more healthy tissue than the situation requires.
Why the community says otherwise
Patient communities have advocated for en bloc for years, on the reasoning that keeping the capsule sealed prevents bacteria, silicone or other material from spilling into the chest during removal. It is a coherent argument, and it is why many women arrive at consultation with en bloc written at the top of their list.
That removing the capsule intact improves systemic symptom outcomes in breast implant illness is widely reported by patients but is not established in the literature. Symptom improvement after explant is reported often, and is worth taking seriously, but it has not been shown to depend on the capsule being removed in one piece.
Bacterial biofilm on implants and within capsules is documented, and its relationship to chronic inflammation is an active area of research. What that means for individual symptoms, and for surgical technique, is not yet settled.
A surgeon who declines to promise en bloc is not necessarily dismissing you. A surgeon who promises it in every case, regardless of findings, is telling you something about their marketing rather than their judgement.
What to ask instead
- Will you remove the entire capsule, and what will you do if it is adherent to my ribs or lung?
- What would make you change technique once you are operating?
- Will the capsule be sent for pathology?
- How many capsulectomies did you perform last year?
- What is your complication rate, and how do you track it?
The useful question is whether all of the capsule comes out and who is judging that in the moment — not whether it leaves your body in one piece.
- Breast Surgery Collaborative Community. Consensus statement on breast implant capsulectomy definitions and management, 2024.
- U.S. Food and Drug Administration. Breast implant labelling recommendations, boxed warning and patient decision checklist, October 2021.
- Aesthetic Surgery Journal Open Forum. En bloc or total intact capsulectomy for self-reported breast implant illness symptoms: prevalence and practice patterns.